1. [Epidermal growth factor up-regulates the mRNA expression of endothelin-1 and its receptors in prostate cancer PC-3 cell lines].
- Author
-
Jia RP, Jiang YF, Xu LW, Wang SK, Wang ZZ, Li WC, and He BS
- Subjects
- Cell Line, Tumor, Humans, Male, Prostatic Neoplasms genetics, Prostatic Neoplasms pathology, RNA, Messenger genetics, RNA, Messenger metabolism, Receptor, Endothelin A genetics, Receptor, Endothelin B genetics, Reverse Transcriptase Polymerase Chain Reaction, Endothelin-1 genetics, Epidermal Growth Factor pharmacology, Gene Expression Regulation, Neoplastic drug effects, Receptors, Endothelin genetics
- Abstract
Objective: To investigate the effects of the epidermal growth factor on the mRNA expression of endothelin-1 and its receptors (ET(A)R, ET(B)R) in hormone refractory prostate cancer (HRPC) PC-3 cell lines., Methods: PC-3 cells were cultured in vitro. After the treatment with EGF, the mRNA expressions of endothelin-1, ET(A)R and ET(B)R were detected by RT-PCR in PC-3 cell lines. The levels of the mRNA expression of endothelin-1 and its receptors were examined at different time points by RT-PCR., Results: The expressions of endothelin-1 and ET(A)R mRNA but not the mRNA expression of ET(B)R was observed in PC-3 cell lines. After 24 hours of treatment with EGF, the expressions of endothelin-1 and ET(A)R in PC-3 cell lines were both up-regulated and there was significant difference (P < 0.05) between the experimental and control groups. Different expression levels of endothelin-1 and ET(A)R mRNA were noted at different time points of EGF intervention, up-regulated with the increase of treatment time, and with significant difference (P < 0.05)., Conclusion: EGF can up-regulate the mRNA expressions of endothelin-1 and ET(A)R in PC-3 cell lines and play a great role in prostate cancer progression, which may offer a substructure of molecular biology for the treatment of HRPC.
- Published
- 2008